If you are taking Ozempic off-label (not approved by the FDA) for weight management, your healthcare provider will guide you on the proper dose to take for your situation
The three ways people currently access retatrutide: Clinical trials: Free pharmaceutical-grade retatrutide with full medical supervision (but you might get placebo) Compounding pharmacies: Legal with a prescription, quality varies, costs $200-500/month Research peptides: Grey market, sold as "not for human consumption," costs $150-500/month, no quality guarantees See our complete guide to getting retatrutide for details on each option
Author contributions All authors contributed to conception and design, analysis and interpretation of the evidence, drafting of the manuscript, finalization of the manuscript, and the decision to submit to publication
It does not establish that the same holds in humans, where no data exist
Your provider will review this with you before prescribing
Inequities in access and adherence to effective treatments have the potential to exacerbate disparities in obesity. GLP-1 Side Effects Lawsuits The two studies come as more than 1,300 lawsuits are currently being pursued against the makers of Ozempic, Wegovy, Mounjaro and other similar diabetes and weight loss drugs, each raising similar allegations that a desire for increased profits was placed above consumer safety by failing to research and disclose gastroparesis side effects users may experience
